Table 5 Responder rates (%) according to weekly incontinence episodes by gender (ITT)
From: Skeletal muscle-derived cell implantation for the treatment of sphincter-related faecal incontinence
|  | Female (N = 34) | Male (N = 5) | All (N = 39) | ||||||
|---|---|---|---|---|---|---|---|---|---|
V2 | V3 | V4 | V2 | V3 | V4 | V2 | V3 | V4 | |
R(0–19) | 16.2 | 10.8 | 10.8 | 13.9 | 8.3 | 11.1 | 15.4 | 10.3 | 10.3 |
R(20–49) | 37.8 | 18.9 | 10.8 | 33.3 | 16.7 | 8.3 | 35.9 | 17.9 | 10.3 |
R(50–99) | 40.5 | 59.5 | 64.9 | 47.2 | 63.9 | 66.7 | 43.6 | 59.0 | 64.1 |
R(100) | 5.4 | 10.8 | 13.5 | 5.6 | 11.1 | 13.9 | 5.1 | 12.8 | 15.4 |